Diosgenin exhibits significant effects in inhibiting tumor growth and metastasis via a reduction in the phosphorylation of IKKβ and NF-κB, leading to the inhibition of TNF-α and IL-6 production in endothelial cells. The gene discussed is IKBKB; the disease is neoplasm.